Company intelligence / Profile preview

HCW Biologics

Miramar, Florida, United Stateshcwbiologics.com ↗
Ownership
Public · HCWB
Employees
~50
Development stage
Other
01

Overview

HCW Biologics has developed two proprietary drug discovery platforms generating multi-functional fusion proteins targeting immune modulation. Lead asset HCW9218 has shown early safety and activity signals in solid tumor patients refractory to chemotherapy. The company’s pipeline includes additional candidates targeting regulatory T cell expansion and immune stimulation. Clinical data are still emerging from ongoing early-phase trials.

Therapeutic areas
OncologyImmunologyCardiovascular
Modalities
Multi-functional fusion proteins (immunotherapies)Protein-based therapeuticsAntibody therapiesImmune cell engagers and stimulators
Industry
Biotech
02

Drug pipeline

12 assets

HCW9218

2

11 more assets in the full pipeline.

03

Partnerships

WY Biotech—license agreement on a Class I immunotherapeutic product candidate combining multiple immune functional domains on a novel scaffold platform.University of Minnesota Masonic Cancer Center—investigator-sponsored trial of HCW9218 in solid tumors.University of Pittsburgh Medical Center—investigator-sponsored trial of HCW9218 in ovarian cancer.
04

Financials

Market cap
$361.5K
Total revenue
$54.2K
Enterprise value
$6.2M

Beyond the preview

Go deeper on HCW Biologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HCW Biologics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call